已收盤 01-02 16:00:00 美东时间
-2.700
-1.49%
今日重点评级关注:Ascendiant Capital:维持SurgePays Inc"买入"评级,目标价从9.5美元升至9.75美元;Ascendiant Capital:维持Outlook Therapeutics"买入"评级,目标价从8美元升至10美元
2025-12-23 12:32
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
2025-12-18 10:54
Argus Research analyst Kevin Heal maintains MarketAxess Holdings (NASDAQ:MKTX) with a Buy and lowers the price target from $212 to $205.
2025-12-17 21:46
MarketAxess (NASDAQ:MKTX) announced on Tuesday that it has authorized the repurchase of up to $400M of additional shares of common stock. The new authorization, combined with the $105M previously anno...
2025-12-09 21:21
The latest announcement is out from Marketaxess Holdings ( ($MKTX) ). On Decemb...
2025-12-09 20:59
U.S. stocks were lower, with the Dow Jones falling around 0.1% on Thursday. Sha...
2025-12-04 23:12
今日重点评级关注:Ascendiant Capital:维持Aclarion"买入"评级,目标价从22美元升至23美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从24美元升至26美元
2025-11-21 15:50
Morgan Stanley analyst Michael Cyprys downgrades MarketAxess Holdings (NASDAQ:MKTX) from Overweight to Equal-Weight and lowers the price target from $247 to $209.
2025-11-20 23:18
今日重点评级关注:Guggenheim:维持InflaRx"买入"评级,目标价从10美元升至22美元;巴克莱:维持Tandem糖尿病护理"超配"评级,目标价从51美元升至55美元
2025-11-11 10:49
Barclays analyst Benjamin Budish maintains MarketAxess Holdings (NASDAQ:MKTX) with a Equal-Weight and raises the price target from $186 to $188.
2025-11-11 02:49